alexa Candida Biofilms and Some Strategies for Prevention | OMICS International
ISSN: 2327-5073
Clinical Microbiology: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Candida Biofilms and Some Strategies for Prevention

Janaina de Cássia Orlandi Sardi*

Faculty of Pharmaceutical Sciences of Department of Clinical Analysis, Laboratory of Clinical Mycology, Univ Paulista (UNESP), Brazil

*Corresponding Author:
Janaina de Cassia Orlandi Sardi
Faculty of Pharmaceutical Sciences
Department of Clinical Analysis
Laboratory of Clinical Mycology
Univ Paulista (UNESP), Brazil
Tel: +55 16 3301 5716
E-mail: [email protected]

Received Date: November 17, 2013; Accepted Date: November 19, 2013; Published Date: November 28, 2013

Citation: Sardi JdeCO (2013) Candida Biofilms and Some Strategies for Prevention Clin Microbial 3:e115. doi: 10.4172/2327-5073.1000e115

Copyright: © 2013 Sardi JdeCO. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Clinical Microbiology: Open Access

Biofilm formation by fungal and bacterial pathogens on implanted medical devices causes major morbidity and mortality among patients, and leads to billions of dollars in healthcare cost. There are estimated to be more than 45 million medical devices implanted every year in the United States. Infection of these devices occurs in 60% of patients, and Candida species are responsible for up to 20% of these infections [1]. Biofilms are complex structures are highly resistant to antimicrobial agents and the host immune system. These cells biofilm, have an altered phenotype with respect to growth rate and gene transcription [2]. Studies have shown that the microorganisms are almost non-existent in their planktonic free form in the tissues of the host, but are grouped together, forming a multicellular community, both in tissues and on prostheses, catheters and other surfaces [3]. Transplantation procedures, immunosuppression, the use of indwelling devices and prolonged intensive care unit stays have increased the prevalence of fungal disease Availability to the inside of medical devices, such as central and peripheral catheters, haemodialysis and peritoneal dialysis units and intracardiac prosthetic valves, facilitates biofilm formation [4]. Biofilm present in the dental plaque was the first to be recognized by the medical community in the 1960s [5]. The formation and accumulation of biofilm on substrates in the oral cavity is the main etiologic factor of oral diseases, candidiasis is one of the most common fungal oral infections diagnosed in humans, with a prevalence of up to 75% in prosthesis users [6]. Patients who underwent hemodialysis and peritoneal dialysis are commonly affected by infections caused by the presence of biofilm [7]. The Candida yeasts are among the main microorganisms isolated from patients with cancer, possibly due to infection with the use of implanted devices for intravenous access. The mechanisms of resistance of the biofilm include extracellular matrix (ECM), efflux pump activity, persisters, cell density, overexpression of drug targets, stress responses, and the general physiology of the cell [8]. Thus, to increase the efficiency of new treatment strategies against bacterial and fungal infections, factors that lead to biofilm growth inhibition, biofilm disruption, or biofilm eradication are being sought. These factors could include enzymes, sodium salts, metal nanoparticles, antibiotics, acids, chitosan derivatives, or plant extracts. Thus, strategies aiming the search for eradicating the biofilms are necessary [9]. More recently, the use of silver nanoparticles (AgNPs) has been suggested for coating medical titanium implants in the hope of inhibiting biofilm formation and thereby reducing the incidence of microbial infections and rejection [10]. Anti-Candida antibodies can reduce the binding of Candida to various surfaces [11]. Studies with antibodies have been performed by various authors to test their effects on various fungal and bacterial organisms. The application of photodynamic therapy has been investigated regarding its inactivation of micro-organisms that are pathogenic to the human host. Several authors have associated light emitting diodes (LEDs) with other substances [12]. More studies has been performed with gold nanoparticle and enhanced photodynamic therapy including the use of methylene blue against recalcitrant pathogenic C. albicans biofilms [13]. Also, because the biofilm matrix is composed of DNA, proteins, and extracellular polysaccharides, recent studies have indicated that the disruption of the biofilm structure could be achieved via degradation of individual biofilm compounds by several enzymes such as DNAse, lactonases, α-amylases [9].

The development of strategies to combat microorganism growing in biofilms is yet a challenging task these bacterial and fungal are much more resistant to classical antimicrobial therapies. Although there are several studies to seek the destruction and removal of biofilms, many studies will be necessary and the way is hard.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12081
  • [From(publication date):
    February-2014 - Jul 17, 2018]
  • Breakdown by view type
  • HTML page views : 8274
  • PDF downloads : 3807

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7